PRESS RELEASE published on 06/20/2024 at 07:30, 2 years 2 months ago OSE Immunotherapeutics présente des données précliniques sur sa plateforme ARNm thérapeutique dans le traitement des maladies auto-immunes et inflammatoires au congrès annuel FOCIS, San Francisco (18 – 21 juin) OSE Immunotherapeutics présente des données précliniques sur sa plateforme ARNm thérapeutique au congrès annuel FOCIS à San Francisco. L'IL-35 joue un rôle clé dans le contrôle des maladies auto-immunes et inflammatoires Maladies Auto-immunes OSE Immunotherapeutics ARNm Thérapeutique IL-35 FOCIS
PRESS RELEASE published on 06/20/2024 at 07:00, 2 years 2 months ago Arbonia sells the “Zelgstrasse” site in Arbon to the HRS Group for around CHF 34 million Arbonia AG sells the 'Zelgstrasse' site in Arbon to HRS Group for around CHF 34 million, leading to positive financial effects. The site is fully leased and part of the company's strategy Real Estate Arbonia AG HRS Group Zelgstrasse Arbon
PRESS RELEASE published on 06/20/2024 at 07:00, 2 years 2 months ago Biophytis grants Blanver exclusive rights to BIO101 in Latin America in deal valued at up to €108 Million Biophytis grants Blanver exclusive rights to BIO101 in Latin America in deal valued at up to €108 million. Agreement includes upfront and milestones payments, double-digit royalties, and collaboration on manufacturing and clinical development Biophytis Latin America Exclusive Rights Blanver Pharmaceutical Deal
PRESS RELEASE published on 06/20/2024 at 07:00, 2 years 2 months ago Biophytis accorde à Blanver les droits exclusifs de BIO101 en Amérique Latine dans un accord pouvant atteindre 108 M€ Biophytis accorde à Blanver les droits exclusifs de BIO101 en Amérique Latine dans un accord pouvant atteindre 108 M€. Accord de licence exclusive pour la commercialisation de BIO101, y compris dans l’obésité et les infections respiratoires Biophytis Accord BIO101 Blanver Am\u00e9rique Latine
REGULATED PRESS RELEASE published on 06/20/2024 at 07:00, 2 years 2 months ago Biophytis accorde à Blanver les droits exclusifs de BIO101 en Amérique Latine dans un accord pouvant atteindre 108 M€ Biophytis accorde à Blanver les droits exclusifs de BIO101 en Amérique Latine dans un accord pouvant atteindre 108 M€ Biophytis Amérique Latine Accord De Licence BIO101 Blanver
REGULATED PRESS RELEASE published on 06/20/2024 at 07:00, 2 years 2 months ago Biophytis grants Blanver exclusive rights to BIO101 in Latin America in deal valued at up to €108 Million Biophytis grants Blanver exclusive rights to BIO101 in Latin America in deal valued at up to €108 Million. Collaboration for commercialization and clinical development announced Biophytis Latin America BIO101 Exclusive Rights Blanver
PRESS RELEASE published on 06/20/2024 at 06:40, 2 years 2 months ago Meyer Burger wins sustainability award for exhibition stand at Intersolar Europe Meyer Burger Technology AG wins Sustainability Award for its exhibition stand at Intersolar Europe, showcasing innovative sustainable trade show concept Meyer Burger Technology AG Intersolar Europe Sustainability Award Sustainable Trade Show Concept EUPD Research
PRESS RELEASE published on 06/20/2024 at 06:00, 2 years 2 months ago Bausch Health Brings Patent Infringement Lawsuit Against Norwich Pharmaceuticals Bausch Health & Salix Pharmaceuticals file lawsuit against Norwich Pharmaceuticals for patent infringement on XIFAXAN. Company defends intellectual property vigorously Salix Pharmaceuticals XIFAXAN Lawsuit Bausch Health Patent Infringement
PRESS RELEASE published on 06/20/2024 at 02:15, 2 years 2 months ago EQS-Adhoc: Dexus Finance Pty Limited: Portfolio valuation update and estimated distribution details - 30 June 2024 Dexus Finance Pty Limited announces portfolio valuation update: decrease of circa $1.3 billion (9.0%) in book values for the six months to 30 June 2024. Estimated distribution details available on 20 August 2024 Real Estate Dividend Dexus Finance Pty Limited Portfolio Valuation Update Estimated Distribution Details
PRESS RELEASE published on 06/20/2024 at 01:10, 2 years 2 months ago Biophytis prolonge son contrat avec Atlas pour sécuriser le financement de ses activités Biophytis prolonge son contrat avec Atlas pour sécuriser le financement de ses activités. Renouvellement de l'accord de financement obligataire pour le lancement de programmes cliniques OBA et MYODA Contrat Biophytis Financement Atlas OBA
Published on 09/16/2026 at 09:40, 1 hour 15 minutes ago VX Logistics Transforms Fresh Fruit and Vegetables Industry Through Application of AI and World-first Robot
Published on 09/16/2026 at 08:30, 2 hours 25 minutes ago FireFox Gold Announces Discovery of the Lammas Zone, Intersecting 21.0m at 4.13 g/t Gold More Than 650m From Previous Drilling at the Mustajärvi Project in Lapland, Finland
Published on 09/16/2026 at 07:30, 3 hours 25 minutes ago Tocvan Expands Near-Surface Gold at El Mezquite: 47.7 m of 0.8 g/t Au Including 2.8 m of 8.4 g/t Au and 54 g/t Ag
Published on 09/16/2026 at 02:05, 8 hours 50 minutes ago Tunkillia Assays Confirm New High-Grade Mineralised Zone Within Shallow, Central Portion of Existing High-Value ‘Starter Pit’ Outlines
Published on 09/16/2026 at 10:30, 25 minutes ago Original-Research: Verve Group Media SE (von GBC AG): BUY
Published on 09/16/2026 at 10:23, 32 minutes ago EQS-Adhoc: BayWa AG: Agreement reached on term sheet for adjusted restructuring agreement; restructuring of hybrid bond planned
Published on 09/16/2026 at 10:14, 40 minutes ago German Tech Investor Jan Beckers Commits €50 Million to Reduce Risks from Advanced AI
Published on 09/16/2026 at 10:05, 50 minutes ago AB Tasty and VWO Unite Under Wingify, Launching a Unified Platform, New Brand Identity, and a Website
Published on 09/16/2026 at 10:05, 50 minutes ago Barcelona launches HOWS Barcelona, a new congress on urban and affordable housing
Published on 09/16/2026 at 07:00, 3 hours 55 minutes ago bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification
Published on 09/16/2026 at 07:00, 3 hours 55 minutes ago bioMérieux obtient le marquage CE IVDR de Classe D pour BIOFIRE® Respiratory 2.1 plus Panel et BIOFIRE® FILMARRAY® Pneumonia plus Panel, les deux premiers tests syndromiques intégrant le MERS-CoV à recevoir à cette certification
Published on 09/15/2026 at 18:00, 16 hours 55 minutes ago Compte-rendu d’Assemblée Générale Mixte du 10 septembre 2026
Published on 09/15/2026 at 18:00, 16 hours 55 minutes ago Report on the Combined General Meeting of the 10th of September 2026
Published on 09/15/2026 at 17:45, 17 hours 10 minutes ago EURAZEO COMPLETES THE ACQUISITION OF NETCO GROUP